Vimarsana
Biggest News Aggregation in the World

Flowr Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Flowr Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Flowr Technology Today - Breaking & Trending Today

Polyphor closes merger with EnBiotix and is renamed Spexis - Vimarsana News

Polyphor closes merger with EnBiotix and is renamed Spexis

Published: December 30, 2021

Polyphor AG / Key word(s): Merger30-Dec-2021 / 07:15 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland, December 30, 2021Polyphor closes merger with EnBiotix and is ren...

Source: pharmiweb.com
Related Topics:
Switzerland GeneralFosun PharmaHernan LevettSilvio InderbitzinFrank WeberPharma GmbRobert ClarkeDan HartmanJuergen FroehlichStephan WehselauBernard BollagDaniel ObrechtHugh OdowdAndreas WallnStephan FeldhausDennis AusielloKuno SommerFlowr TechnologyEnbiotix IncInternational Reporting StandardSwiss ExchangeShareholder MeetingJeffrey WagerHugho DowdExecutive Committee
Polyphor and EnBiotix Announce Dosing of First Patient in a First-in-Human Clinical Trial of Inhaled Murepavadin - Vimarsana News

Polyphor and EnBiotix Announce Dosing of First Patient in a First-in-Human Clinical Trial of Inhaled Murepavadin

Published: December 15, 2021

Press release content from Accesswire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
United StatesSwitzerland GeneralPharma GmbEnbiotix GmbHernan LevettStephan FeldhausEnbiotix IncPolyphor LtdCystic Fibrosis FoundationSwiss ExchangeFlowr TechnologyEuropean Innovative Medicines InitiativeUniversity Of ZurichInhalation SolutionJeffrey WagerChief Executive OfficerOuter Membrane Protein Targeting AntibioticsClinical TrialsCystic FibrosisPolyphor Ag